However, the “classical” pediatric brain tumors-associated genomic alterations (such as MYC amplifications or TP53 deletions [20, 26]) were maintained in MB-R cells and we could not identify any evident correlation between retrieved CNEs and dysregulated genes (not shown). This evidence concerns the gene TP53 and brain neoplasm.